World Class Team

Racho Jordanov (Co-Founder, President & CEO of JHL Biotech, Inc.)

Racho Jordanov

Co-Founder, Co-Chairman, President and CEO

Racho Jordanov is a biotech pioneer with more than 30 years of experience building and leading manufacturing operations in development-stage and multi-national biopharmaceutical companies. Mr. Jordanov started his career with Genentech, Inc. in 1981 in San Francisco, where he led the facility start-up and managed on-going commercial manufacturing of the first biotech products to be approved by FDA: insulin and rhGH.

Over his 20-year career at Genentech Mr. Jordanov was at the forefront of innovations in biopharmaceutical manufacturing, from introducing the first processes for monoclonal antibody (mAb) production, to establishing Genentech’s outsourcing capabilities for drug substance, drug product and medical devices, to most recently starting-up new biomanufacturing facilities in the US and Singapore.

In addition to Genentech, Mr. Jordanov led North America manufacturing operations for Serono S.A. (now Merck Serono; Switzerland) and served as the Vice President of Manufacturing and Operations for two California-based biotech start-ups: Cholestech and Telios Pharmaceuticals.

Mr. Jordanov earned his B.A. in Biology from the University of California, San Diego, and an M.B.A. from National University in San Diego.

Rose Lin (Co-Founder and General Manager of JHL Biotech, Inc., Taiwan)

Rose Lin

Co-Founder, COO and General Manager (JHL Taiwan)

Rose is the co-founder and COO of JHL Biotech, Inc., Cayman as well as the General Manager of JHL Biotech, Taiwan. She is a true believer and supporter of JHL Biotech’s mission statement, to make affordable world- class biological therapeutics. Her experience in the industry has enabled her to gather a group of passionate biotech veterans and implement lean manufacturing processes using innovative technology, governed by top notch quality control systems.

Rose is the President and Founder of TLC Charities, Inc. which was established in December 2006 in California, USA. TLC Charities, Inc. financially supports and encourages disadvantaged children in their endeavors for education. Rose is a dreamer with passion and enthusiasm. Her goal is to combine the missions of JHL Biotech and TLC Charities to make this world a better place to live.

Rose worked at Genentech from 1987-2009 in various departments such as GMP Systems, Clinical Manufacturing, Clinical Packaging, Commercial Packaging and Biochemical Project Manager and worked at Eusol Biotech, Inc. as a plant director from 2009-2012. She holds a B.S. degree in pharmacy and is a registered pharmacist in Taiwan.

Peter Pang (VP of Regulatory Affairs and Head of Operations at JHL Biotech, Inc., Wuhan)

Peter Pang, Ph.D.

General Manager of JHL Wuhan and EVP Corporate Regulatory Affairs

From 2008 to 2013, he was General Manager, Scientific Affairs and later Assistant Director, Regulatory Affairs at New B Innovation Ltd where he directed the nonclinical development and regulatory programs for human and veterinary oxygen carrying therapeutics.

Rong Chen (Chief Medical Officer)

Rong Chen, MD, Ph.D.

Chief Medical Officer

Dr. Chen joins the company from his previous role as Chief Medical Officer at Phagelux, a biologics company in Shanghai, Chief Medical Officer at CASI Pharmaceuticals, Vice President and Head of Regulatory Excellence for China/HK area at GlaxoSmithKline, Medical Director for the Asia Pacific region at Bayer Schering Pharma, and Medical Director for China at Sanofi. He also previously held several clinical and research positions in Australia.

Ellis Chu (Chief Financial Officer)

Ellis Chu

Chief Financial Officer

Prior to joining JHL Biotech, Ellis was a Managing Director and the Head of Greater China at Ion Pacific, an Asia-focused VC Merchant Bank. Prior to Ion Pacific, Ellis was an investment banker and Head of China Mergers & Acquisitions at Bank of America Merrill Lynch. Ellis began his finance career in New York before transferring to Asia with Lehman Brothers in 2007. He has also held senior investment banking positions at Citigroup, Nomura and Lehman Brothers advising on transaction across multiple sectors including healthcare.

Sohail Qureshi (VP of Quality)

Sohail Qureshi

VP of Corporate Quality

Sohail is a certified ISO 9001:2008 and cGMP lead auditor with over 20 years cGMP quality leadership experience in biotechnology industry including development and deployment of quality systems and business processes to ensure regulatory compliance and business needs. Prior to joining JHL, Sohail has worked at Genentech (San Francisco and Singapore), Imclone/Eli Lilly, MONSANTO, and NovoNordisk/Novozymes (North America) within various quality functions including both QA and QC.

Andreas Nechansky (VP of Research and Analytical Operations)

Andreas Nechansky, Ph.D.

VP of Research and Analytical Operations

Dr. Andreas Nechansky has more than 15 years of experience in the biotech industry and his last position was Chief Operating Officer of a GMP certified analytical service provider. His experience lies within the field of analytical characterization of Biopharmaceuticals and Biosimilars with a strong focus on Bioassays.

Joseph Liu, Ph.D. (Sr. Director of Drug Products Process Development - Formulation)

Joseph Liu, Ph.D.

Sr. Director of Drug Products Process Development (Formulation)

Dr. Liu has more than 14 years of pharmaceutical experience in strategic, managing and technical roles for the therapeutic biologics development from early phase to commercial phase. He has profound experience in Formulation development, Analytical method development and Technical transfer.  In addition, he also has some practical experience of cGMP, CMC coordination related to biologic pipelines and Regulatory requirements from several BLA filings while he was working at Lilly.

Allen Ho (Sr. Director of Regulatory Technical CMC)

Allen Ho, Ph.D.

Sr. Director of Regulatory Technical CMC

Dr. Ho has more than 17 years of biotech research experience of which with 6+ years in Regulatory Affairs.
He has strong experience in method development, transfer, and validation to support IND and BLA and is also familiar with CFDA, EMEA, US Regulation on IND filing. Before joining JHL, Dr. Ho was the Head of Research and Development at PharmaEssentia Corp.

Mahalia Corrales (Director of Process Development)

Mahalia Corrales

Director of Late Stage Process Development

Mahalia is an accomplished and results-oriented leader in Biologics Drug Substance Manufacturing with 18+ years serving in various leadership roles in Process Development, Manufacturing Sciences and Technology, Engineering, and Drug Substance Commercial Manufacturing. Prior to joining JHL, she was an Associate Director, Manufacturing Technical Support and later, Engineering at Genentech Oceanside Operations.

KC Carswell (VP of Process Development)


Member of Scientific Advisory Board

Dr. KC Carswell was a Principal Engineer at Genentech, leading teams in Process Development and Manufacturing Sciences. KC assisted in development of next generation processes for several blockbuster products, and has also lead the transfer of commercial manufacturing processes to new facilities around the world.

Zack Zheng, Ph.D.

VP of Wuhan MSAT (Manufacturing Science and Technology)

Yen Hsieh

Sr. Director of Corporate Human Resource & Administration

Jason Lin

Director of Corporate Procurement and MML (Material Management & Logistics)

Lin Chen, Ph.D.

Director of Wuhan Quality Control

Fred Shaw

Director of Taiwan Engineering and Engineering Projects

Henry Wu

Director of Wuhan Engineering and Corporate Projects

James Chang

Sr. Director of Wuhan Quality Assurance

DJ Lin

Director of Corporate Legal

JHL’s leadership team is dedicated to fostering a dynamic change-driven culture
committed to meeting the needs of our customers.